Fig. 6From: TTK is a potential therapeutic target for cisplatin-resistant ovarian cancerTTK was significantly overexpressed after ovarian cancer patients became cisplatin resistance. Samples from tissue chip with different expression against TTK protein in ovarian cancer patients before and after cisplatin resistanceBack to article page